BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11955348)

  • 21. Differences in factors associated with oncogenic and nononcogenic human papillomavirus infection at the United States-Mexico border.
    Giuliano AR; Papenfuss M; Abrahamsen M; Inserra P
    Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):930-4. PubMed ID: 12223441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Australian women's needs and preferences for information about human papillomavirus in cervical screening.
    McCaffery K; Irwig L
    J Med Screen; 2005; 12(3):134-41. PubMed ID: 16156944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus infection and cervical cancer in Latin America.
    Reeves WC; Brinton LA; García M; Brenes MM; Herrero R; Gaitán E; Tenorio F; de Britton RC; Rawls WE
    N Engl J Med; 1989 Jun; 320(22):1437-41. PubMed ID: 2541336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genital human papilloma virus infection in mentally-institutionalized virgins.
    Shimada T; Miyashita M; Miura S; Nakayama D; Miura K; Fukuda M; Masuzaki H
    Gynecol Oncol; 2007 Sep; 106(3):488-9. PubMed ID: 17532028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys.
    Vaccarella S; Franceschi S; Herrero R; Muñoz N; Snijders PJ; Clifford GM; Smith JS; Lazcano-Ponce E; Sukvirach S; Shin HR; de Sanjosé S; Molano M; Matos E; Ferreccio C; Anh PT; Thomas JO; Meijer CJ;
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):326-33. PubMed ID: 16492924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean.
    Almonte M; Albero G; Molano M; Carcamo C; García PJ; Pérez G
    Vaccine; 2008 Aug; 26 Suppl 11():L16-36. PubMed ID: 18945400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. International correlation between human papillomavirus prevalence and cervical cancer incidence.
    Maucort-Boulch D; Franceschi S; Plummer M;
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):717-20. PubMed ID: 18349293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence and risk factors for human papillomavirus in Taiwan.
    Wang IJ; Viscidi R; Hwang KC; Lin TY; Chen CJ; Huang LM; Chen HH; Chen CJ
    J Trop Pediatr; 2008 Feb; 54(1):14-8. PubMed ID: 17984124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Human papillomaviruses infections among village women in Henan province].
    Li XL; Wang H; Li CQ; Wu YP; Liu JH; Song D; Liu XF; Qiao YL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jun; 41 Suppl():77-80. PubMed ID: 17767864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica.
    Herrero R; Castle PE; Schiffman M; Bratti MC; Hildesheim A; Morales J; Alfaro M; Sherman ME; Wacholder S; Chen S; Rodriguez AC; Burk RD
    J Infect Dis; 2005 Jun; 191(11):1796-807. PubMed ID: 15871111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The epidemiology of human papillomavirus infections.
    Baseman JG; Koutsky LA
    J Clin Virol; 2005 Mar; 32 Suppl 1():S16-24. PubMed ID: 15753008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The interval between menarche and age of first sexual intercourse as a risk factor for subsequent HPV infection in adolescent and young adult women.
    Kahn JA; Rosenthal SL; Succop PA; Ho GY; Burk RD
    J Pediatr; 2002 Nov; 141(5):718-23. PubMed ID: 12410205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of human papilloma virus (HPV) infection in Italian women.
    Cercato MC; Mariani L; Vocaturo A; Carrone A; Terrenato I; Morano G; Benevolo M; Rollo F; Germelli C; Paolini F; Venuti A
    J Med Virol; 2010 Nov; 82(11):1921-7. PubMed ID: 20872720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
    Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
    J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A survey of female nursing students' knowledge, health beliefs, perceptions of risk, and risk behaviors regarding human papillomavirus and cervical cancer.
    Denny-Smith T; Bairan A; Page MC
    J Am Acad Nurse Pract; 2006 Feb; 18(2):62-9. PubMed ID: 16460412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the etiology of anal squamous carcinoma.
    Frisch M
    Dan Med Bull; 2002 Aug; 49(3):194-209. PubMed ID: 12238281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cervical cancer. Current view of its epidemiology and risk factors].
    Torres Lobatón A; Rojo Herrera G; Torres Rojo A; Hurtado Estrada G; Román Bassaure E
    Ginecol Obstet Mex; 2004 Sep; 72():466-74. PubMed ID: 15587822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of risk factors for persistent infection of asymptomatic women with high-risk human papilloma virus.
    Shi N; Lu Q; Zhang J; Li L; Zhang J; Zhang F; Dong Y; Zhang X; Zhang Z; Gao W
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-7. PubMed ID: 28409676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.